Dupilumab Linked to Higher Psoriasis Risk in AD

Compared with other systemic agents for treating atopic dermatitis, dupilumab is associated with an increased risk for psoriasis in a cohort study.
Medscape Medical News

source https://www.medscape.com/viewarticle/dupilumab-linked-higher-psoriasis-risk-atopic-dermatitis-2025a1000gbo?src=rss